Tower Research Capital (TRC)’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.04K | Buy |
2,763
+1,709
| +162% | +$4.97K | ﹤0.01% | 4026 |
|
|
2025
Q1 | $2.64K | Sell |
1,054
-1,387
| -57% | -$3.47K | ﹤0.01% | 4521 |
|
|
2024
Q4 | $7.86K | Buy |
2,441
+1,363
| +126% | +$4.39K | ﹤0.01% | 4036 |
|
|
2024
Q3 | $2.79K | Sell |
1,078
-386
| -26% | -$1K | ﹤0.01% | 4936 |
|
|
2024
Q2 | $3.37K | Buy |
1,464
+1,431
| +4,336% | +$3.29K | ﹤0.01% | 4897 |
|
|
2024
Q1 | $106 | Buy |
+33
| New | +$106 | ﹤0.01% | 5651 |
|
|
2023
Q2 | – | Sell |
-664
| Closed | -$6K | – | 6062 |
|
|
2023
Q1 | $6K | Sell |
664
-164
| -20% | -$1.48K | ﹤0.01% | 4833 |
|
|
2022
Q4 | $11K | Buy |
828
+376
| +83% | +$5K | ﹤0.01% | 3802 |
|
|
2022
Q3 | $8K | Sell |
452
-226
| -33% | -$4K | ﹤0.01% | 4770 |
|
|
2022
Q2 | $8K | Sell |
678
-195
| -22% | -$2.3K | ﹤0.01% | 4665 |
|
|
2022
Q1 | $19K | Sell |
873
-264
| -23% | -$5.75K | ﹤0.01% | 3571 |
|
|
2021
Q4 | $39K | Sell |
1,137
-300
| -21% | -$10.3K | ﹤0.01% | 2967 |
|
|
2021
Q3 | $88K | Buy |
+1,437
| New | +$88K | ﹤0.01% | 2505 |
|
|
2021
Q2 | – | Sell |
-335
| Closed | -$19K | – | 5524 |
|
|
2021
Q1 | $19K | Buy |
335
+64
| +24% | +$3.63K | ﹤0.01% | 3911 |
|
|
2020
Q4 | $17K | Sell |
271
-949
| -78% | -$59.5K | ﹤0.01% | 3958 |
|
|
2020
Q3 | $148K | Buy |
1,220
+961
| +371% | +$117K | ﹤0.01% | 2829 |
|
|
2020
Q2 | $31K | Buy |
259
+113
| +77% | +$13.5K | ﹤0.01% | 3414 |
|
|
2020
Q1 | $8K | Buy |
+146
| New | +$8K | ﹤0.01% | 2111 |
|
|
2019
Q4 | – | Sell |
-189
| Closed | -$46K | – | 3676 |
|
|
2019
Q3 | $46K | Buy |
189
+68
| +56% | +$16.6K | ﹤0.01% | 1850 |
|
|
2019
Q2 | $28K | Buy |
+121
| New | +$28K | ﹤0.01% | 1940 |
|